Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection (162 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021 May 21; DOI:10.2174/09298673: 1-1.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 4.53, 5-year impact factor: 4.961
Url: DOI: 10.2174/0929867328666210521164809
Keywords: Coronavirus, Coronavirus Infections, Pandemics, Covid-19, Hcov, Sars-Cov, Mers-Cov, Vaccine, Biontech, Pfizer, Moderna, Oxford, Astrazeneca, Bnt162b2, Mrna-1273, Chadox1-S, Biontech Pfizer , Oxford Astrazeneca,
Affiliations:
*** IBB - CNR ***
Michele Costanzo1,2, Maria Anna Rachele De Giglio3 and Giovanni Nicola Roviello4,*
1Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples
'Federico II', Via S. Pansini 5, I-80131 Naples, Italy; 2CEINGE - Biotecnologie Avanzate Scarl, Via G. Salvatore
486, I-80145 Naples, Italy; 3School of Medicine and Surgery, University of Naples 'Federico II', Via S.
Pansini 5, I-80131 Naples, Italy; 4Instituto di Biostrutture e Bioimmagini IBB - CNR; Via Mezzocannone 16,
I-80134 Naples, Italy
References:
Not available.
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021 May 21; DOI:10.2174/09298673: 1-1.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 4.53, 5-year impact factor: 4.961
Url: DOI: 10.2174/0929867328666210521164809
Keywords: Coronavirus, Coronavirus Infections, Pandemics, Covid-19, Hcov, Sars-Cov, Mers-Cov, Vaccine, Biontech, Pfizer, Moderna, Oxford, Astrazeneca, Bnt162b2, Mrna-1273, Chadox1-S, Biontech Pfizer , Oxford Astrazeneca,
Affiliations:
*** IBB - CNR ***
Michele Costanzo1,2, Maria Anna Rachele De Giglio3 and Giovanni Nicola Roviello4,*
1Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples
'Federico II', Via S. Pansini 5, I-80131 Naples, Italy; 2CEINGE - Biotecnologie Avanzate Scarl, Via G. Salvatore
486, I-80145 Naples, Italy; 3School of Medicine and Surgery, University of Naples 'Federico II', Via S.
Pansini 5, I-80131 Naples, Italy; 4Instituto di Biostrutture e Bioimmagini IBB - CNR; Via Mezzocannone 16,
I-80134 Naples, Italy
References:
Not available.
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
The aim of this review article is to summarize the knowledge available to date on prophylaxis achievements to fight against Coronavirus. This work will give an overview of what is reported in the most recent literature on vaccines (under investigation or already developed like BNT162b2, mRNA-1273, and ChAdOx1-S) effective against the most pathogenic Coronaviruses (SARS-CoV-1, MERS-CoV-1, and SARS-CoV-2), with of course particular attention paid to those under development or already in use to combat the current COVID-19 (COronaVIrus Disease 19) pandemic. Our main objective is to make a contribution to the comprehension, additionally at a molecular level, of what is currently ready for anti-SARS-CoV-2 prophylactic intervention, as well as to provide the reader with an overall picture of the most innovative approaches for the development of vaccines that could be of general utility in the fight against the most pathogenic Coronaviruses.
The aim of this review article is to summarize the knowledge available to date on prophylaxis achievements to fight against Coronavirus. This work will give an overview of what is reported in the most recent literature on vaccines (under investigation or already developed like BNT162b2, mRNA-1273, and ChAdOx1-S) effective against the most pathogenic Coronaviruses (SARS-CoV-1, MERS-CoV-1, and SARS-CoV-2), with of course particular attention paid to those under development or already in use to combat the current COVID-19 (COronaVIrus Disease 19) pandemic. Our main objective is to make a contribution to the comprehension, additionally at a molecular level, of what is currently ready for anti-SARS-CoV-2 prophylactic intervention, as well as to provide the reader with an overall picture of the most innovative approaches for the development of vaccines that could be of general utility in the fight against the most pathogenic Coronaviruses.
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
| ▼ A multi-targeting approach to fight COVID-19 |
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
Other filter: ([btitle,keywords] "Coronavirus" OR [bti ...
Sandomenico A, Ruggiero A, Iaccarino E, Oliver A, Squeglia F, Moreira M, Esposito L, Ruvo M, Berisio R
* Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation (112 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2023 May 10; 24(10): 500-519.
Impact Factor: 6.21
View Export to BibTeX Export to EndNote
Costanzo M, De Giglio MAR, Roviello GN
* Deciphering the Relationship between SARS-CoV-2 and Cancer (42 views)
Int J Mol Sci (ISSN: 1422-0067linking), 2023 Apr 25; 24(9): 7803-7803.
Impact Factor: 5.6
View Export to BibTeX Export to EndNote
Vicidomini C, Roviello GN
* Potential Anti-SARS-CoV-2 Molecular Strategies (51 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2023 Feb 24; 28(5): 2118-2123.
Impact Factor: 4.6
View Export to BibTeX Export to EndNote
Ricci A, Roviello GN
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV (142 views)
Life, 2023 Feb; 13: 402-417.
Impact Factor: 3.2
View Export to BibTeX Export to EndNote
Squeglia F, Romano M, Esposito L, Barra G, Campiglia P, Sala M, Scala MC, Ruggiero A, Berisio R
* Structure-Based Development of SARS-CoV-2 Spike Interactors (70 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2022 May 17; 23(10): N/D-N/D.
Impact Factor: 6.21
View Export to BibTeX Export to EndNote
Perrella F, Coppola F, Petrone A, Platella C, Montesarchio D, Stringaro A, Ravagnan G, Fuggetta MP, Rega N, Musumeci D
* Interference of Polydatin/Resveratrol in the ACE2: Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays (98 views)
Biomolecules (ISSN: 2218-273xlinking), 2021 Jul 16; 11(7): N/D-N/D.
Impact Factor: 4.57
View Export to BibTeX Export to EndNote
Roviello V, Musumeci D, Mokhir A, Roviello GN
* Evidence of Protein Binding by a Nucleopeptide Based on a Thyminedecorated L-Diaminopropanoic Acid through CD and In Silico Studies (132 views) (PDF 27 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021 Jul; 28(24): 5004-5015.
Impact Factor: 4.53
View Export to BibTeX Export to EndNote
Di Gaetano S, Capasso D, Delre P, Pirone L, Saviano M, Pedone E, Mangiatordi GF
* More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells (167 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2021 Jun 16; 22 (12 ): N/D-N/D.
Impact Factor: 2.598
View Export to BibTeX Export to EndNote
Vicidomini C, Roviello V, Roviello GN
* Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L. ) and Clues to Its Anti-COVID-19 Utility (241 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2021 Mar 26; 26(7): 1880-1886.
Impact Factor: 4.411
View Export to BibTeX Export to EndNote
Borbone N, Piccialli G, Roviello GN, Oliviero G
* Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses (233 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2021 Feb 13; 26(4): 986-1002.
Impact Factor: 4.411
View Export to BibTeX Export to EndNote
Cella L, Gagliardi G, Hedman M, Palma G
* Injuries From Asymptomatic COVID-19 Disease: New Hidden Toxicity Risk Factors in Thoracic Radiation Therapy (129 views) (PDF 34 views)
Int J Radiat Oncol (ISSN: 0360-3016linking, 1879-355x), 2020 Oct 1; 108(2): 394-396.
Impact Factor: 5.859
View Export to BibTeX Export to EndNote
Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R
* A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping (760 views)
Cells (ISSN: 2073-4409linking, 2073-4409electronic), 2020 May 20; 9(5): 1297-1297.
Impact Factor: 6.6
View Export to BibTeX Export to EndNote
Testino G, Fagoonee S
* Coronavirus disease 2019 outbreak: liver disease a prognostic tool? (147 views)
Panminerva Med (ISSN: 0031-0808linking, 1827-1898electronic), 2020 May 14; N/D: N/D-N/D.
Impact Factor: 3.467
View Export to BibTeX Export to EndNote
D'Andrea A, Radmilovic J, Carbone A, Forni A, Tagliamonte E, Riegler L, Liccardo B, Crescibene F, Sirignano C, Esposito G, Bossone E
* Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis (146 views) (PDF 19 views)
World Journal Of Radiology, 2020 May; 21(5): 345-353.
Impact Factor: 0.57
View Export to BibTeX Export to EndNote
Costanzo M, De Giglio MAR, Roviello GN
* SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus (505 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2020 Apr 16; 27(27): 4536-4541.
Impact Factor: 4.184
View Export to BibTeX Export to EndNote
* Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation (112 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2023 May 10; 24(10): 500-519.
Impact Factor: 6.21
View Export to BibTeX Export to EndNote
Costanzo M, De Giglio MAR, Roviello GN
* Deciphering the Relationship between SARS-CoV-2 and Cancer (42 views)
Int J Mol Sci (ISSN: 1422-0067linking), 2023 Apr 25; 24(9): 7803-7803.
Impact Factor: 5.6
View Export to BibTeX Export to EndNote
Vicidomini C, Roviello GN
* Potential Anti-SARS-CoV-2 Molecular Strategies (51 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2023 Feb 24; 28(5): 2118-2123.
Impact Factor: 4.6
View Export to BibTeX Export to EndNote
Ricci A, Roviello GN
Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV (142 views)
Life, 2023 Feb; 13: 402-417.
Impact Factor: 3.2
View Export to BibTeX Export to EndNote
Squeglia F, Romano M, Esposito L, Barra G, Campiglia P, Sala M, Scala MC, Ruggiero A, Berisio R
* Structure-Based Development of SARS-CoV-2 Spike Interactors (70 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2022 May 17; 23(10): N/D-N/D.
Impact Factor: 6.21
View Export to BibTeX Export to EndNote
Perrella F, Coppola F, Petrone A, Platella C, Montesarchio D, Stringaro A, Ravagnan G, Fuggetta MP, Rega N, Musumeci D
* Interference of Polydatin/Resveratrol in the ACE2: Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays (98 views)
Biomolecules (ISSN: 2218-273xlinking), 2021 Jul 16; 11(7): N/D-N/D.
Impact Factor: 4.57
View Export to BibTeX Export to EndNote
Roviello V, Musumeci D, Mokhir A, Roviello GN
* Evidence of Protein Binding by a Nucleopeptide Based on a Thyminedecorated L-Diaminopropanoic Acid through CD and In Silico Studies (132 views) (PDF 27 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021 Jul; 28(24): 5004-5015.
Impact Factor: 4.53
View Export to BibTeX Export to EndNote
Di Gaetano S, Capasso D, Delre P, Pirone L, Saviano M, Pedone E, Mangiatordi GF
* More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells (167 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic), 2021 Jun 16; 22 (12 ): N/D-N/D.
Impact Factor: 2.598
View Export to BibTeX Export to EndNote
Vicidomini C, Roviello V, Roviello GN
* Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L. ) and Clues to Its Anti-COVID-19 Utility (241 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2021 Mar 26; 26(7): 1880-1886.
Impact Factor: 4.411
View Export to BibTeX Export to EndNote
Borbone N, Piccialli G, Roviello GN, Oliviero G
* Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses (233 views)
Molecules (ISSN: 1420-3049linking, 1420-3049electronic), 2021 Feb 13; 26(4): 986-1002.
Impact Factor: 4.411
View Export to BibTeX Export to EndNote
Cella L, Gagliardi G, Hedman M, Palma G
* Injuries From Asymptomatic COVID-19 Disease: New Hidden Toxicity Risk Factors in Thoracic Radiation Therapy (129 views) (PDF 34 views)
Int J Radiat Oncol (ISSN: 0360-3016linking, 1879-355x), 2020 Oct 1; 108(2): 394-396.
Impact Factor: 5.859
View Export to BibTeX Export to EndNote
Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R
* A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping (760 views)
Cells (ISSN: 2073-4409linking, 2073-4409electronic), 2020 May 20; 9(5): 1297-1297.
Impact Factor: 6.6
View Export to BibTeX Export to EndNote
Testino G, Fagoonee S
* Coronavirus disease 2019 outbreak: liver disease a prognostic tool? (147 views)
Panminerva Med (ISSN: 0031-0808linking, 1827-1898electronic), 2020 May 14; N/D: N/D-N/D.
Impact Factor: 3.467
View Export to BibTeX Export to EndNote
D'Andrea A, Radmilovic J, Carbone A, Forni A, Tagliamonte E, Riegler L, Liccardo B, Crescibene F, Sirignano C, Esposito G, Bossone E
* Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis (146 views) (PDF 19 views)
World Journal Of Radiology, 2020 May; 21(5): 345-353.
Impact Factor: 0.57
View Export to BibTeX Export to EndNote
Costanzo M, De Giglio MAR, Roviello GN
* SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus (505 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2020 Apr 16; 27(27): 4536-4541.
Impact Factor: 4.184
View Export to BibTeX Export to EndNote
15 Records (15 excluding Abstracts).
Total impact factor: 67.02 (67.02 excluding Abstracts).
Total 5 year impact factor: 58.059 (58.059 excluding Abstracts).
Total impact factor: 67.02 (67.02 excluding Abstracts).
Total 5 year impact factor: 58.059 (58.059 excluding Abstracts).
162 views. Last view on Friday 06 September 2024, 12:50:35
ibb.cnr.it
